Recruiting NA Cervical Radiculopathy

New treatment option for Cervical Radiculopathy

Official title Mulligan Mobilization & Stretching Effects of Cervical

ClinicalTrials.gov ID: NCT07045974

What this study is testing

What it's testing
1. To evaluate the effectiveness of mulligan mobilization and stretching exercises in reducing pain in individuals with cervical radiculopathy.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 20 to 50

You may be able to join if

  • Participants falling in this category would be recruited into the study.
  • Both genders
  • Age between 20-50 years
  • people with neck pain radiating down to the arm
  • Patients with positive findings for spurling test, Upper Limb Tension Test (ULTT), cervical distraction test and cervical rotation test towards the...

You likely can't join if

  • Participant failing to fall in this category would be excluded of the study.
  • Systemic disease potentially affecting the musculoskeletal system Patients experiencing primary shoulder or upper extremity problem of local origin
  • Patients with any cardiovascular disorders and respiratory disorders
  • Patients with any other pathological conditions involving cervical spine like vertebro basilar insufficiency and canal stenosis
  • Patients having osteophytes in cervical vertebrae
  • Patients who were undergoing treatment for neck pain with other means of physiotherapy at the time of the study
See the full eligibility criteria
Who can join
  • Participants falling in this category would be recruited into the study.
  • Both genders
  • Age between 20-50 years
  • people with neck pain radiating down to the arm
  • Patients with positive findings for spurling test, Upper Limb Tension Test (ULTT), cervical distraction test and cervical rotation test towards the symptomatic side
  • people who were willing to participate in the study and willing to take treatment for cervical radiculopathy.
What rules you out
  • Participant failing to fall in this category would be excluded of the study.
  • Systemic disease potentially affecting the musculoskeletal system Patients experiencing primary shoulder or upper extremity problem of local origin
  • Patients with any cardiovascular disorders and respiratory disorders
  • Patients with any other pathological conditions involving cervical spine like vertebro basilar insufficiency and canal stenosis
  • Patients having osteophytes in cervical vertebrae
  • Patients who were undergoing treatment for neck pain with other means of physiotherapy at the time of the study
  • Hypermobile joints of cervical vertebrae, Cervical fractures, spinal surgery or other spinal pathologies (i.e. ankylosing spondylitis, spondylolysthesis)
  • Peripheral nerve lesions like neurotemesis and axonotemesis

The study team makes the final eligibility decision.

Where it's taking place

  • Peshawar, KPK, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 20 years to 50 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Peshawar, KPK, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.